← Back to Clinical Trials
Recruiting NCT06354959

NCT06354959 Prehab for Lung and Esophageal Cancer

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06354959
Status Recruiting
Phase
Sponsor Nova Scotia Health Authority
Condition Neoplasm of Lung
Study Type INTERVENTIONAL
Enrollment 25 participants
Start Date 2024-06-01
Primary Completion 2026-06-01

Eligibility & Interventions

Sex All sexes
Min Age 18 Years
Max Age N/A
Study Type INTERVENTIONAL
Interventions
Prehabilitation

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 25 participants in total. It began in 2024-06-01 with a primary completion date of 2026-06-01.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

Research indicates that individuals diagnosed with lung or esophageal cancer who enter treatment with higher functional capacities, improved body composition, and better nutrition status tend to experience better outcomes and a higher quality of life. The primary objective of a prehabilitation health coaching program is to enhance the overall health and well-being of patients before they undergo major surgery.This personalized 8-week program encompasses elements such as nutrition, smoking cessation, sleep hygiene, and movement, equipping participants with the knowledge and tools needed to adopt healthier lifestyles.

Eligibility Criteria

Inclusion Criteria: * Diagnosed with lung or esophageal cancer * Scheduled to receive surgical intervention in minimum 2-weeks * Surgeon approval * Able to read and write in English * \>18 years of age Exclusion Criteria: * Not able to provide informed consent

Frequently Asked Questions

Who can join the NCT06354959 clinical trial?

This trial is open to participants of all sexes, aged 18 Years or older, studying Neoplasm of Lung. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06354959 currently recruiting?

Yes, NCT06354959 is actively recruiting participants. Visit ClinicalTrials.gov or contact Nova Scotia Health Authority to inquire about joining.

Where is the NCT06354959 trial being conducted?

This trial is being conducted at Halifax, Canada.

Who is sponsoring the NCT06354959 clinical trial?

NCT06354959 is sponsored by Nova Scotia Health Authority. The trial plans to enroll 25 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology